NEW ISSUE
May 10
Davide Capodanno
The special EuroPCR 2024 issue with the VARC-HBR consensus document; a debate on systematic OCT use in PCI; outcomes by sex from the ISCHEMIA trial; the DECISION QFR trial; CART in contemporary CTO PCI; SAPIEN 3 Ultra RESILIA; predictors of late lumen loss after DCBs for de novo lesions; new-onset atrial fibrillation after TAVI; and more!
VIEWPOINT
May 10
Hélène Eltchaninoff
Alain Cribier, an interventional cardiologist, developed the techniques of balloon aortic valvuloplasty and transcatheter aortic valve implantation, which have revolutionized the treatment of aortic stenosis.
free
ORIGINAL RESEARCH
May 10
Masanori Yamamoto, Kentaro Hayashida et al.
This study compared the clinical outcomes and valve performance of the latest-generation SAPIEN 3 Ultra RESILIA (S3UR) valve to the previous-generation SAPIEN 3 (S3) valve in patients undergoing transcatheter aortic valve replacement (TAVR). The S3UR showed lower rates of paravalvular leakage and patient-prosthesis mismatch.
ORIGINAL RESEARCH
May 10
Taku Asano, Hitoshi Matsuo et al.
The FAVOR III Europe Japan trial aims to randomize 2000 patients to either a QFR-guided or FFR-guided strategy to evaluate whether QFR yields non-inferior 12-month clinical outcomes compared to FFR for intermediate coronary stenosis.
EDITORIAL
May 10
Patrick W. Serruys, Pruthvi C. Revaiah
The content discusses the importance of a multidisciplinary Heart Team approach in decision-making between CABG and PCI for complex coronary artery disease, and the potential use of QFR parameters in predicting clinical outcomes.
free
EDITORIAL
May 10
Roxana Mehran, Mauro Gitto
The article highlights the underrepresentation of women in cardiovascular clinical trials and the undertreatment of women with coronary artery disease in real-world practice, emphasizing the need for innovative strategies to include more women in trials and tailor management approaches.
free
ORIGINAL RESEARCH
May 10
Mario Gaudino, Bjorn Redfors et al.
In the ISCHEMIA trial, women with stable coronary artery disease were less likely to undergo revascularization than men, but the effect of an invasive versus conservative management strategy was similar between sexes.
Join the EuroIntervention Challenge
May 10
Participate in the EuroIntervention Challenge—an exciting test of your interventional cardiology knowledge and enthusiasm! Plus, stand a chance to win a free ticket to EuroPCR 2025!
ORIGINAL RESEARCH
May 8
Adil Salihu et al.
This study evaluated the ability of ChatGPT-4, a large language model, to assist in the decision-making process of Multidisciplinary Heart Teams for the management of severe aortic stenosis, finding a 77% agreement rate with the Heart Team's decisions.
RESEARCH CORRESPONDENCE
May 8
Gennaro Giustino, Pedro A. Villablanca et al.
This study reports the outcomes of 22 patients with refractory cardiogenic shock who underwent transcaval venoarterial extracorporeal membrane oxygenation, with a 54.6% in-hospital mortality rate and a high incidence of vascular and bleeding complications.
EDITORIAL
May 8
Valentin Koch
A study examines the use of ChatGPT in augmenting the decision-making processes of Heart Teams in the treatment of severe aortic stenosis, suggesting a high degree of alignment between the language model and the multidisciplinary teams.
free
EDITORIAL
Apr 23
Harold L. Dauerman, Rony Lahoud et al.
This study examined the outcomes of 914 patients with severely reduced left ventricular ejection fraction (≤30%) who underwent TAVI, finding that prior myocardial infarction, reduced kidney function, and low-flow, low-gradient aortic stenosis were associated with higher mortality.
free
EDITORIAL
Apr 23
Barbara E. Stähli, Julia Stehli et al.
This substudy of the BIOVASC trial suggests that immediate multivessel PCI is an effective and safe strategy for ACS patients with multivessel coronary artery disease, including complex three-vessel disease.
free
TRIAL DESIGN
Apr 23
Flavio Ribichini, Giuseppe Tarantini et al.
FAITAVI is a randomized trial comparing angiography-guided versus physiology-guided coronary revascularization in patients with severe aortic valve stenosis and coronary artery disease undergoing TAVI.
Trending articles
Antiplatelet therapy after percutaneous coronary intervention
Transcatheter treatment for tricuspid valve disease
Intravascular ultrasound guidance for lower extremity arterial and venous interventions
Myocardial infarction with non-obstructive coronary artery disease
Crush techniques for percutaneous coronary intervention of bifurcation lesions
Management of coronary artery disease in patients undergoing transcatheter aortic valve implantation. A clinical consensus statement from the European Association of Percutaneous Cardiovascular Interventions in collaboration with the ESC Working Group on Cardiovascular Surgery
Impact of mitral regurgitation aetiology on the outcomes of transcatheter aortic valve implantation
Single antiplatelet therapy directly after percutaneous coronary intervention in non-ST-segment elevation acute coronary syndrome patients: the OPTICA study
Feasibility of redo-TAVI in self-expanding Evolut valves: a CT analysis from the Evolut Low Risk Trial substudy
Device-related thrombus following left atrial appendage occlusion
State-of-the-Art Review
10.4244/EIJ-D-21-00904
•
Apr 1, 2022
Angiolillo D et al
free
State-of-the-Art Review
10.4244/EIJ-D-21-00695
•
Nov 19, 2021
Praz F et al
free
Expert consensus
10.4244/EIJ-D-21-00898
•
Sep 20, 2022
Secemsky E et al
free
State-of-the-Art Review
10.4244/EIJ-D-21-00426
•
Dec 3, 2021
Lindahl B et al
free
Expert review
10.4244/EIJ-D-21-00690
•
May 15, 2022
Moroni F et al
free
Expert consensus
10.4244/EIJ-D-22-00958
•
May 12, 2023
Tarantini G et al
free
Clinical research
10.4244/EIJ-D-22-01062
•
Aug 21, 2023
Doldi PM et al
Clinical research
10.4244/EIJ-D-22-00886
•
May 12, 2023
van der Sangen NM et al
Clinical research
10.4244/EIJ-D-22-01125
•
Jul 17, 2023
Grubb KJ et al
Expert review
10.4244/EIJ-D-21-01010
•
Jun 24, 2022
Simard T et al
free
